Anacetrapib is a cholesteryl ester transfer protein (CETP) inhibitor used as an active pharmaceutical ingredient. It increases serum HDL-cholesterol levels and decreases LDL-cholesterol levels by reducing cholesteryl ester transfer from HDL to LDL or VLDL.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Anacetrapib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Growth hormone releasing hexapeptide
pharmaceutical raw material
Atenolol impurity D
pharmaceutical raw material
Trandolapril
pharmaceutical raw material
3-(1-piperazinyl)-1,2-benzisothiazole
pharmaceutical raw material
The international HS code for Anacetrapib (CAS 875446-37-0) is 2934.99.
2934.99
2934 99 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-[[2-(4-fluoro-2-methoxy-5-propan-2-ylphenyl)-5-(trifluoromethyl)phenyl]methyl]-4-methyl-1,3-oxazolidin-2-one
MZZLGJHLQGUVPN-HAWMADMCSA-N
C[C@H]1[C@H](OC(=O)N1CC2=C(C=CC(=C2)C(F)(F)F)C3=CC(=C(C=C3OC)F)C(C)C)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F
Sourcing Anacetrapib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.